vascular disease Flashcards
Pathophysiology - causes of vascular disease
- Atherosclerosis - almost always this
- Inflammatory arterial disease
- Vasospastic
- Compression
- Traumatic
- Pro-thrombotic conditions
different areas mainly affected
lower limbs
brain
visceral - renal
aneurysms
Risk Factors modifiable
Smoking
Hypertension
Diabetes
Hypercholesterolaemia
Risk Factors - Non modifiable
Age
men
symptoms in acute vs chronic LL vascular disease
Acute Ischaemia:
- 6Ps
Pulselessness
Pallor
Pain
Perishingly cold
Paralysis
Paresthesia
- Acute-embolus (AF, MI)
- Acute on chronic-thrombus
Chronic Ischaemia:
- Intermittent clocication - no pain at rest but during exercise
- foot pain at rest
- Tissue loss - necrosis / gangrene
- Burgers test
buergers test
- patient lies in the supine position
- elevate legs to 45 degree angle upwards
- in 1-2 minutes the patients feet should go pallor (pale) indicating blood loss
- then get the patient to sit over the bed and see how long it takes for the feet to return to their original colour / red
- longer than 10-15s suggests ischemia
types of aneurysms
True
- Weakening of the arterial wall leading to dilatation
Commonest location is the infra-renal aorta
False / pseudo
Mycotic
Investigations
- history of risk factors
- duplex ultrasound and cross sectional imagine - identify blockage
- Bloods – Lipids,
Glucose,
Renal function,
Vasculitic screen,
Clotting, FBC
ABPI
ABPI
- measure systolic BP in ankles and arm
- divide the ankle result / brachial result and this is the ABPI
results:
> 1.3: Non-compressible arteries (e.g., due to calcification in diabetes).
0.9–1.3: Normal.
0.6–0.89: Mild to moderate PAD.
< 0.4: Severe PAD or critical limb ischemia.
Treatment
Risk factor modification
Antiplatelets
Statin
Stop smoking
Good control of BP
Good control of DM
ACE inhibitors?
Exercise programme
Invasive treatment –Lower Limbs
endovascular (through the artery:
- Stenoses
- Short occlusions
- DEB - balloon coated with cytostatic drug - transferred to the arterial wall, inhibiting smooth muscle proliferation, which causes restenosis.
- DES - stent coated with anti-proliferative drug - inhibit endothelial cell proliferation, reducing scar tissue
Bypass surgery (around the artery)
Better patency and limb salvage rates
Higher morbidity and mortality
bigger procedure - more risks
abdominal aortic treatment
Endovascular
Morphology
Lower morbidity and mortality
Life long surveillance
Open surgery
Higher initial morbidity and mortality
Lower long term morbidity and mortality
Carotid Disease procedure
Carotid Endarterectomy:
- incision in neck to open the artery and take the plaque out
Endovascular stenting:
- catheter in femoral artery to place stent in artery